I think that the comparative context for understanding the deficiencies in Canada's model is vitally important, because when one looks at the rich countries in the OECD zone, one finds that for most countries that have universal health insurance, they also have a universal drug insurance plan as part of that. Canada is a bit of an outlier in that regard, and because of that Canada has some of the highest drug prices in the rich industrialized world.
While there may not be a single country's model that one would simply adopt wholesale in reforming the Canadian model, there are very many components in many countries that are comparators for Canada that are worth looking at closely. There's New Zealand among small countries but also larger, wealthier countries as well.
I think what we know is that the principles involved, which involve universality, a single buyer, a national comprehensive formulary and the like, are the tenets, the principles, that one wants to adopt from different models rather than simply hunting for a single country that has the perfect drug insurance plan.